Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
<p>Tumor percentages estimated from H&E images and comparison between HR, ovaHRDScar and Telli2016 status.</p>
Saved in:
| Hovedforfatter: | |
|---|---|
| Andre forfattere: | , , , , , , , , , , , , , , , , , , , , |
| Udgivet: |
2025
|
| Fag: | |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
| _version_ | 1849927631939567616 |
|---|---|
| author | Sanna Pikkusaari (15055802) |
| author2 | Manuela Tumiati (15011915) Anni Virtanen (15055805) Jaana Oikkonen (14948281) Yilin Li (15055808) Fernando Perez-Villatoro (15055811) Taru Muranen (15055814) Matilda Salko (15055817) Kaisa Huhtinen (15055820) Anna Kanerva (15055823) Heidi Koskela (15055826) Johanna Tapper (15055829) Riitta Koivisto-Korander (15055832) Titta Joutsiniemi (15055835) Ulla-Maija Haltia (15055838) Heini Lassus (15055841) Sampsa Hautaniemi (14948308) Anniina Färkkilä (14948278) Johanna Hynninen (14932815) Sakari Hietanen (14932818) Olli Carpén (14932812) Liisa Kauppi (15055844) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Sanna Pikkusaari (15055802) Manuela Tumiati (15011915) Anni Virtanen (15055805) Jaana Oikkonen (14948281) Yilin Li (15055808) Fernando Perez-Villatoro (15055811) Taru Muranen (15055814) Matilda Salko (15055817) Kaisa Huhtinen (15055820) Anna Kanerva (15055823) Heidi Koskela (15055826) Johanna Tapper (15055829) Riitta Koivisto-Korander (15055832) Titta Joutsiniemi (15055835) Ulla-Maija Haltia (15055838) Heini Lassus (15055841) Sampsa Hautaniemi (14948308) Anniina Färkkilä (14948278) Johanna Hynninen (14932815) Sakari Hietanen (14932818) Olli Carpén (14932812) Liisa Kauppi (15055844) |
| author_role | author |
| dc.creator.none.fl_str_mv | Sanna Pikkusaari (15055802) Manuela Tumiati (15011915) Anni Virtanen (15055805) Jaana Oikkonen (14948281) Yilin Li (15055808) Fernando Perez-Villatoro (15055811) Taru Muranen (15055814) Matilda Salko (15055817) Kaisa Huhtinen (15055820) Anna Kanerva (15055823) Heidi Koskela (15055826) Johanna Tapper (15055829) Riitta Koivisto-Korander (15055832) Titta Joutsiniemi (15055835) Ulla-Maija Haltia (15055838) Heini Lassus (15055841) Sampsa Hautaniemi (14948308) Anniina Färkkilä (14948278) Johanna Hynninen (14932815) Sakari Hietanen (14932818) Olli Carpén (14932812) Liisa Kauppi (15055844) |
| dc.date.none.fl_str_mv | 2025-11-25T13:30:59Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30709567 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S2_from_Functional_Homologous_Recombination_Assay_on_FFPE_Specimens_of_Advanced_High-Grade_Serous_Ovarian_Cancer_Predicts_Clinical_Outcomes/30709567 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Prognostic biomarkers Chemotherapy DNA Damage and Repair Drug Resistance Clinical drug resistance Gynecological Cancers Ovarian cancer Precision Medicine |
| dc.title.none.fl_str_mv | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Tumor percentages estimated from H&E images and comparison between HR, ovaHRDScar and Telli2016 status.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_9cfe332917a882e6007644cb79306ea7 |
| identifier_str_mv | 10.1158/1078-0432.30709567 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30709567 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical OutcomesSanna Pikkusaari (15055802)Manuela Tumiati (15011915)Anni Virtanen (15055805)Jaana Oikkonen (14948281)Yilin Li (15055808)Fernando Perez-Villatoro (15055811)Taru Muranen (15055814)Matilda Salko (15055817)Kaisa Huhtinen (15055820)Anna Kanerva (15055823)Heidi Koskela (15055826)Johanna Tapper (15055829)Riitta Koivisto-Korander (15055832)Titta Joutsiniemi (15055835)Ulla-Maija Haltia (15055838)Heini Lassus (15055841)Sampsa Hautaniemi (14948308)Anniina Färkkilä (14948278)Johanna Hynninen (14932815)Sakari Hietanen (14932818)Olli Carpén (14932812)Liisa Kauppi (15055844)CancerMolecular and Cellular BiologyCancer Detection and DiagnosisTherapeutic Research and DevelopmentClinical Research and TrialsBiomarkersPrognostic biomarkersChemotherapyDNA Damage and RepairDrug ResistanceClinical drug resistanceGynecological CancersOvarian cancerPrecision Medicine<p>Tumor percentages estimated from H&E images and comparison between HR, ovaHRDScar and Telli2016 status.</p>2025-11-25T13:30:59ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709567https://figshare.com/articles/dataset/Supplementary_Table_S2_from_Functional_Homologous_Recombination_Assay_on_FFPE_Specimens_of_Advanced_High-Grade_Serous_Ovarian_Cancer_Predicts_Clinical_Outcomes/30709567CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307095672025-11-25T13:30:59Z |
| spellingShingle | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes Sanna Pikkusaari (15055802) Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Prognostic biomarkers Chemotherapy DNA Damage and Repair Drug Resistance Clinical drug resistance Gynecological Cancers Ovarian cancer Precision Medicine |
| status_str | publishedVersion |
| title | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_full | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_fullStr | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_full_unstemmed | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_short | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| title_sort | Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes |
| topic | Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Prognostic biomarkers Chemotherapy DNA Damage and Repair Drug Resistance Clinical drug resistance Gynecological Cancers Ovarian cancer Precision Medicine |